Rentokil Initial buys back 4.13M ordinary shares

Following the planned cancellation, Rentokil Initial plc will have 2,521,907,313 ordinary shares in issue; it currently holds no shares in treasury.

Available on EDGAR 11/10/2026 - 06:04 AM EST Accepted by SEC EDGAR 11/10/2026 - 06:04 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Rentokil Initial plc (RTO) purchased ordinary shares through Goldman Sachs International on the London Stock Exchange from November 2 through November 6, 2026, under authority granted by shareholders at the May 7, 2026 annual general meeting. Since October 27, 2026, the company has purchased 4,132,572 ordinary shares and intends to cancel the purchased shares. The purchases were carried out under instructions issued by the company on October 27, 2026, as announced on October 22, 2026. Following cancellation, 2,521,907,313 ordinary shares will be in issue. The company states it does not hold any shares in treasury. It says the post-cancellation share count may be used as the denominator for calculating whether shareholders and others with notification obligations must notify interests or changes in interests under the FCA’s Disclosure Guidance and Transparency Rules.

Key Figures

Ordinary shares purchased: 4,132,572 ordinary shares Ordinary shares in issue: 2,521,907,313 ordinary shares Volume weighted price paid per share: £3.5320 per share +4 more

7 metrics

Ordinary shares purchased 4,132,572 ordinary shares Since October 27, 2026

Ordinary shares in issue 2,521,907,313 ordinary shares Following cancellation of the repurchased shares

Volume weighted price paid per share £3.5320 per share Purchase table; November 2–6, 2026

Volume weighted price paid per share £3.5388 per share Purchase table; November 2–6, 2026

Volume weighted price paid per share £3.5602 per share Purchase table; November 2–6, 2026

Volume weighted price paid per share £3.6051 per share Purchase table; November 2–6, 2026

Volume weighted price paid per share £3.5187 per share Purchase table; November 2–6, 2026

Key Terms

Volume weighted price paid per share, ordinary shares in issue, shares in treasury, Disclosure Guidance and Transparency Rules, +1 more

5 terms

Volume weighted price paid per share financial

"Volume weighted price paid per share"

ordinary shares in issue financial

"the Company has 2,521,907,313 ordinary shares in issue"

shares in treasury financial

"The Company does not hold any shares in treasury"

Disclosure Guidance and Transparency Rules regulatory

"under the FCA's Disclosure Guidance and Transparency Rules"

Disclosure guidance and transparency rules are the standards and regulations that require companies to share clear, timely information about their finances, risks, operations and material events. They matter to investors because consistent, honest reporting is like a car’s dashboard — it reveals the data you need to judge safety and performance and make informed buying or selling decisions. Strong disclosure reduces surprises and helps keep markets fair and efficient.

Market Abuse Regulation regulatory

"the Market Abuse Regulation"

Market abuse regulation consists of laws and rules designed to prevent dishonest or manipulative practices in financial markets. It aims to ensure fair and transparent trading, so investors can trust that markets operate honestly, much like rules that keep a game fair. By reducing unfair advantages, it helps protect investor confidence and promotes healthy, efficient markets.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares has Rentokil Initial (RTO) bought since October 27, 2026?

Rentokil Initial plc reports purchases of 4,132,572 ordinary shares since October 27, 2026. Purchases from November 2 through November 6 were made through Goldman Sachs International on the London Stock Exchange.

What prices did Rentokil Initial (RTO) pay per share?

The purchase table lists volume-weighted prices of £3.5320, £3.5388, £3.5602, £3.6051 and £3.5187 per share for purchases during November 2 through November 6, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________________

FORM 6-K

__________________

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2026

Commission File Number: 001-41524

___________________________________

Rentokil Initial plc

(Registrant’s name)

___________________________________

Compass House

Manor Royal

Crawley

West Sussex RH10 9PY

United Kingdom

(Address of principal executive office)

_____________________________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Transaction in Own Shares dated 10 November 2026

10 November 2026

Rentokil Initial plc (the "Company")

Purchase of own shares

The Company announces that, from 02 November 2026 up to and including 06 November 2026, it has purchased the following number of its ordinary shares through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 7 May 2026 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 27 October 2026 as announced on 22 October 2026.

Date of Purchase	Number of ordinary shares purchased	Volume weighted price paid per share	Lowest price paid per share	Highest price paid per share
2026-11-02	464,386	£3.5320	£3.4780	£3.5730
2026-11-03	454,598	£3.5388	£3.5200	£3.5640
2026-11-04	458,113	£3.5602	£3.4950	£3.6030
2026-11-05	450,481	£3.6051	£3.5770	£3.6340
2026-11-06	449,769	£3.5187	£3.4780	£3.5550

The Company intends to cancel the purchased shares.

Following the cancellation of the repurchased shares, the Company has 2,521,907,313 ordinary shares in issue. The Company does not hold any shares in treasury. This information may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Since 27 October 2026, the Company has purchased 4,132,572 ordinary shares.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), full details of the transactions, in aggregated and detailed form, are available at:

http://www.rns-pdf.londonstockexchange.com/rns/4355C_1-2026-11-9.pdf

Enquiries:

For further information, please contact:

Investors / Analysts:

Heather Wood, Rentokil Initial plc, +44 7808 098793

Jamie Lewis, Rentokil Initial plc, +44 7341 071944

Media:

Malcolm Padley, Rentokil Initial plc, +44 7788 978 199

About Rentokil Initial plc

Rentokil Initial plc is a global leader in Pest Control and Hygiene & Wellbeing services. It employs c.63,400 people in 90 countries.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: 10 November 2026	RENTOKIL INITIAL PLC
	/s/ Rachel Canham
	Name: Rachel Canham
	Title: Group General Counsel and Company Secretary